Lexicon Pharmaceuticals (LXRX) Current Assets (2010 - 2026)
Lexicon Pharmaceuticals (LXRX) posted quarterly Current Assets of $186.0 million for Q1 2026, down 24.32% year-over-year from $245.8 million in Q1 2025, and up 82.57% quarter-over-quarter from $101.9 million in Q4 2025.
Lexicon Pharmaceuticals (LXRX) Current Assets (2010 - 2026) Analysis & Trends
Lexicon Pharmaceuticals (LXRX) has reported Current Assets for 17 consecutive years, with $186.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Assets fell 24.32% year-over-year to $186.0 million; the TTM figure through Mar 2026 stood at $186.0 million (down 24.32% YoY), while the FY2025 annual figure was $101.9 million, down 58.61% from the prior year.
- Current Assets climbed to $186.0 million in Q1 2026 per LXRX's latest filing, from $101.9 million in the prior quarter.
- Across five years, Current Assets topped out at $364.6 million in Q1 2024 and bottomed at $64.9 million in Q2 2022.
- Historically, Current Assets has averaged $188.7 million across 5 years, with a median of $176.5 million in 2023.
- Annual changes were most pronounced in 2023 — Current Assets jumped 306.36% — and 2025, when it slumped 58.61%.
- Lexicon Pharmaceuticals' Current Assets stood at $140.9 million in 2022, then rose by 25.33% to $176.5 million in 2023, then surged by 39.45% to $246.2 million in 2024, then tumbled by 58.61% to $101.9 million in 2025, then jumped by 82.57% to $186.0 million in 2026.
- Business Quant data shows LXRX's Current Assets at $186.0 million in Q1 2026, $101.9 million in Q4 2025, and $122.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 8.07 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.03 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 7.22 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 11.83 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 1.76 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.62 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.63 Bn |
| 10 | Lexicon Pharmaceuticals | 1.04 Bn | 846.13 Mn | 653,000.00 | 196.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 196.58 Mn |
| Mar 31, 2026 | 186.03 Mn |
| Dec 31, 2025 | 101.90 Mn |
| Sep 30, 2025 | 122.53 Mn |
| Jun 30, 2025 | 145.08 Mn |
| Mar 31, 2025 | 245.81 Mn |
| Dec 31, 2024 | 246.19 Mn |
| Sep 30, 2024 | 268.61 Mn |
| Jun 30, 2024 | 320.84 Mn |
| Mar 31, 2024 | 364.65 Mn |
| Dec 31, 2023 | 176.55 Mn |
| Sep 30, 2023 | 223.37 Mn |
| Jun 30, 2023 | 263.72 Mn |
| Mar 31, 2023 | 109.55 Mn |
| Dec 31, 2022 | 140.87 Mn |
| Sep 30, 2022 | 139.06 Mn |
| Jun 30, 2022 | 64.90 Mn |
| Mar 31, 2022 | 88.43 Mn |
| Dec 31, 2021 | 88.92 Mn |
| Sep 30, 2021 | 124.01 Mn |